Literature DB >> 33988951

High Attention-Deficit/Hyperactivity Disorder Scale Scores Among Patients with Persistent Chronic Nonspecific Low Back Pain.

Satoshi Kasahara1, Shin-Ichi Niwa2, Ko Matsudaira3, Naoko Sato4, Hiroyuki Oka5, Tomoko Fujii5, Shin-Ichi Konno6, Shin-Ichi Kikuchi6, Yoshitsugu Yamada7.   

Abstract

BACKGROUND: Associations between attention-deficit/hyperactivity disorder (ADHD) and chronic pain disorders, such as fibromyalgia, have been reported. However, associations between persistent chronic nonspecific low back pain (CNLBP) and ADHD have not yet been investigated.
OBJECTIVES: This study aimed to investigate the positive rates of possible ADHD, as assessed by self-reported ADHD scales, in patients with persistent CNLBP, using data from self-reported questionnaires completed by patients and their families. This study also aimed to compare the self-reported scores obtained from existing standardized data for healthy individuals, and to examine whether the ADHD scale scores of patients with persistent CNLBP are associated with pain variables. STUDY
DESIGN: Cross-sectional study.
SETTING: The specialized pain clinic at our university hospital.
METHODS: This cross-sectional study included 60 consecutive patients with persistent CNLBP who were diagnosed with a possible somatic symptom disorder and were referred to a psychiatrist in our pain clinic. The Conners' Adult ADHD Rating Scales (CAARS) self-report (CAARS-S) and observer-rated (CAARS-O) questionnaires were utilized. We investigated the CAARS scores, and the association between the CAARS subscale scores and pain variables (pain duration and pain Numeric Rating Scale) in patients with persistent CNLBP.
RESULTS: Of the 60 patients, 19 (31.7%) were positive on both CAARS-S and CAARS-O questionnaires (T-score > 65). The ADHD indices, which comprised subscales of the CAARS estimating the necessity of treatment for ADHD, were significantly higher in both male and female patients with persistent CNLBP than in the Japanese standardized sample (P < 0.005). CAARS-S hyperactivity/restlessness, CAARS-O hyperactivity/restlessness, and the Diagnostic and Statistical Manual of Mental Disorders, fourth edition hyperactive-impulsive symptom subscale scores also correlated with the pain intensity (P < 0.05). LIMITATIONS: In this study, ADHD tendency was evaluated using only a self-reported questionnaire. Hence in the future, accurate and precise assessments of ADHD symptoms using structured clinical interviews conducted by ADHD experts are warranted. Additionally, the study only included patients with persistent CNLBP. Therefore in the future, it will be valuable to investigate ADHD scale scores (e.g., CAARS) among patients with CNLBP and nonspecific low back pain with larger sample sizes.
CONCLUSIONS: Our findings revealed that the subscale scores on an ADHD scale were considerably high in patients with persistent CNLBP. As a previous study of our clinical experience indicates that persistent CNLBP can be substantially relieved by administering ADHD medications, ADHD screening is warranted in the treatment of persistent CNLBP.

Entities:  

Keywords:  Conners’ Adult ADHD Rating Scales (CAARS); Numeric Rating Scale; chronic nonspecific low back pain; chronic pain; neurodevelopmental disorders; pain clinic; pain duration; somatic symptom disorder zzm321990; Attention-deficit/hyperactivity disorder

Year:  2021        PMID: 33988951

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  2 in total

1.  Case report: Treatment of persistent atypical odontalgia with attention deficit hyperactivity disorder and autism spectrum disorder with risperidone and atomoxetine.

Authors:  Satoshi Kasahara; Chihiro Takao; Ko Matsudaira; Naoko Sato; Trang Thi Huyen Tu; Shin-Ichi Niwa; Kanji Uchida; Akira Toyofuku
Journal:  Front Pain Res (Lausanne)       Date:  2022-07-22

2.  Attention-Deficit/hyperactivity disorder and centralized pain: A review of the case of John F. Kennedy.

Authors:  Satoshi Kasahara; Ko Matsudaira; Naoko Sato; Shin-Ichi Niwa
Journal:  Clin Case Rep       Date:  2022-10-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.